Viatris appoints Carmen Ferrara as new Medical Affairs Director for Italy
Published
Viatris, one of the largest pharmaceutical companies in the world, has announced the appointment of Carmen Ferrara as the new Medical Affairs Director for Italy. The news was reported by Daily Health Industry, a publication specialising in the healthcare sector.
The Medical Affairs role is very important for a pharmaceutical company. This function is responsible for providing scientific information on medicines, monitoring clinical studies and collecting data on product safety. It also maintains dialogue with doctors, specialists and healthcare facilities, to ensure that information on treatments is accurate, up to date and based on scientific evidence.
Viatris was born in 2020 from the merger between Mylan and the Upjohn division of Pfizer. The company produces generic medicines, branded medicines and biosimilar products, and operates in many countries around the world, including Italy. The appointment of a new head of Medical Affairs in our country shows the company's attention to the Italian market.
At present, the information available is limited. No details have been disclosed about Carmen Ferrara's professional background or the exact date on which her new appointment will begin. Any updates may be provided directly by the company or by specialist sources in the sector.
Sources: Daily Health Industry -
More Italy news
- ASE Technology's Revenue Rises 47.1% in October
- La Financière de l'Échiquier strengthens its technology sector with a new appointment
- Claude Code flaw: sensitive data at risk online
- Fiber optics in Italy: how the network that brings internet into homes really works
- Grande Sicilia Bets on Young People: "Generazione Autonomista" Meeting in Syracuse on December 5
- From Online Insults to Support: An Idea for Women in Politics
- Arms decree for Ukraine: tension in government, Giorgetti has not yet signed
- Valditara calls for withdrawal of Laterza history textbook: "It indoctrinates students"